Toru Mochizuki
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Peroxisome Proliferator-Activated Receptors 2
-
- Antimicrobial Resistance in Staphylococcus 4
- Infection Control in Healthcare 2
-
- Cancer Cells and Metastasis 3
-
- Pneumonia and Respiratory Infections 3
-
- Nosocomial Infections in ICU 3
-
- Pelvic and Acetabular Injuries 2
- Co-authors
- Takashi KadowakiKoji MurakamiMakoto OhashiKazuyuki TobeY AkanumaY YazakiTatsuro IdeNoboru Yanaihara
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Diabetes (1 paper)
- Partner nations
- JapanNetherlandsUnited States
In The Last Decade
Toru Mochizuki
29 papers receiving 512 citations
Peers
Comparison fields: 5 of 91
- Cellular and Molecular Neuroscience 91
- Applied Microbiology and Biotechnology 9
- Biochemistry 32
- Molecular Biology 298
- Physiology 111
Countries citing papers authored by Toru Mochizuki
This map shows the geographic impact of Toru Mochizuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Mochizuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Mochizuki more than expected).
Fields of papers citing papers by Toru Mochizuki
This network shows the impact of papers produced by Toru Mochizuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Mochizuki. The network helps show where Toru Mochizuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toru Mochizuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2020 | 3 | |
| 3 | 2018 | 10 | |
| 4 | 2018 | 4 | |
| 5 | 2009 | 5 | |
| 6 | 2009 | 22 | |
| 7 | 2008 | 1 | |
| 8 | 2008 | 2 | |
| 9 | 2008 | 31 | |
| 10 | 2006 | 1 | |
| 11 | 2006 | 15 | |
| 12 | 2004 | 23 | |
| 13 | 2004 | 9 | |
| 14 | 2002 | 13 | |
| 15 | 1998 | 37 | |
| 16 | 1990 | 7 | |
| 17 | 1988 | 0 | |
| 18 | [Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice]. | 1984 | 1 |
| 19 | 1983 | 27 | |
| 20 | [Gastrointestinal hormones--chemistry and biochemistry (author's transl)]. | 1979 | 1 |
About Toru Mochizuki
Toru Mochizuki is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Biochemistry, having authored 31 papers that have together received 541 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Cancer Cells and Metastasis (3 papers), Pneumonia and Respiratory Infections (3 papers), Nosocomial Infections in ICU (3 papers), Infection Control in Healthcare (2 papers), Pelvic and Acetabular Injuries (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (91 citations), Applied Microbiology and Biotechnology (9 citations) and Biochemistry (32 citations). Toru Mochizuki has collaborated with scholars based in Japan, Netherlands and United States. Frequent co-authors include Takashi Kadowaki, Koji Murakami, Makoto Ohashi, Kazuyuki Tobe, Y Akanuma, Y Yazaki, Tatsuro Ide, Noboru Yanaihara, Kunihiro Mashiko and Chizuko Yanaihara. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.